Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-002627
Filing Date
2025-02-03
Accepted
2025-02-03 17:22:21
Documents
1
Period of Report
2025-01-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 10434
  Complete submission text file 0001437749-25-002627.txt   12093
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Issuer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SHUTTLE PHARMACEUTICALS HOLDINGS, INC. ONE RESEARCH COURT, SUITE 450 ROCKVILLE MD 20850
Business Address
Schafer Joshua (Reporting) CIK: 0001945557 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 25583825